Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fat-soluble vitamins for injection (II)
- Development stage
- Phase 3
- Lead developer
- ShanXi PuDe Pharmaceutical
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
**Fat-soluble vitamins for injection (II)** is an approved combination drug containing four essential fat-soluble vitamins: Vitamin A (retinol palmitate), Vitamin D2 (ergocalciferol), Vitamin E (alpha-tocopherol), and Vitamin K1 (phytomenadione). Developed and manufactured by ShanXi PuDe Pharmaceutical and other Chinese pharmaceutical companies, it is indicated as a nutritional supplement for patients receiving parenteral nutrition to prevent or treat fat-soluble vitamin deficiencies. The formulation is administered intravenously, typically reconstituted and added to intravenous infusions such as glucose or saline solutions, to meet the daily physiological requirements of these vitamins in adult and pediatric patients who cannot tolerate oral intake.
- Other names
- Fat-soluble Vitamin For Injection (II)Fat-soluble Vitamin(II) for Injection注射用脂溶性维生素(II)注射用脂溶性维生素（II）
02
Targets
GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)RARA (Retinoic acid receptor alpha)RARB (Retinoic acid receptor beta)RARG (Retinoic acid receptor gamma)RXRA (Retinoid X receptor alpha)RXRB (Retinoid X receptor beta)RXRG (RXRγ)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on fat-soluble vitamins for injection (II).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fat-soluble vitamins for injection (II).